36.34
1.79%
0.64
After Hours:
36.34
Doximity Inc stock is traded at $36.34, with a volume of 1.24M.
It is up +1.79% in the last 24 hours and up +38.44% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
See More
Previous Close:
$35.70
Open:
$35.91
24h Volume:
1.24M
Relative Volume:
0.78
Market Cap:
$6.75B
Revenue:
$468.33M
Net Income/Loss:
$137.63M
P/E Ratio:
66.07
EPS:
0.55
Net Cash Flow:
$161.60M
1W Performance:
-1.20%
1M Performance:
+38.44%
6M Performance:
+29.28%
1Y Performance:
+51.04%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SAN FRANCISCO
Doximity Inc Stock (DOCS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-24 | Initiated | Barclays | Equal Weight |
Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
Aug-09-23 | Downgrade | Needham | Buy → Hold |
Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Oct-31-22 | Initiated | Wells Fargo | Overweight |
Oct-24-22 | Initiated | Evercore ISI | In-line |
Oct-13-22 | Initiated | BTIG Research | Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-07-22 | Initiated | Truist | Hold |
Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
Jul-28-22 | Initiated | Berenberg | Buy |
May-18-22 | Reiterated | BofA Securities | Neutral |
May-18-22 | Reiterated | Goldman | Buy |
May-18-22 | Reiterated | Guggenheim | Buy |
May-18-22 | Reiterated | Jefferies | Buy |
May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
May-18-22 | Reiterated | Needham | Buy |
Apr-07-22 | Initiated | Guggenheim | Buy |
Apr-04-22 | Initiated | BofA Securities | Neutral |
Feb-11-22 | Initiated | Goldman | Buy |
Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
Dec-02-21 | Initiated | Jefferies | Buy |
Nov-17-21 | Initiated | Robert W. Baird | Outperform |
Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
Nov-10-21 | Reiterated | Goldman | Neutral |
Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
Nov-10-21 | Reiterated | Needham | Buy |
Nov-10-21 | Reiterated | Piper Sandler | Overweight |
Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
Jul-19-21 | Initiated | Canaccord Genuity | Buy |
Jul-19-21 | Initiated | Goldman | Neutral |
Jul-19-21 | Initiated | JP Morgan | Overweight |
Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
Jul-19-21 | Initiated | Piper Sandler | Overweight |
Jul-19-21 | Initiated | Raymond James | Outperform |
Jul-19-21 | Initiated | SVB Leerink | Outperform |
Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Principal Financial Group Inc. Has $11.38 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Is Doximity, Inc.'s (NYSE:DOCS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Simply Wall St
Bank of New York Mellon Corp Has $32.02 Million Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Raymond James & Associates Reduces Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity re-elects directors, ratifies auditor for FY 2025 - Investing.com
Doximity (NASDAQ:DOCS) Reaches New 12-Month High at $37.28 - MarketBeat
Doximity stock hits 52-week high at $37.28 amid robust growth - Investing.com Canada
Doximity stock hits 52-week high at $37.28 amid robust growth - Investing.com Australia
Doximity stock hits 52-week high at $37.28 amid robust growth By Investing.com - Investing.com South Africa
Doximity stock hits 52-week high at $37.28 amid robust growth - Investing.com
Doximity stock hits 52-week high at $37.28 amid robust growth - Investing.com UK
Doximity stock hits 52-week high at $37.28 amid robust growth - Investing.com India
Should You Buy This Stock After It Skyrocketed by 33%? - AOL
Nisa Investment Advisors LLC Acquires 11,000 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Should You Buy This Stock After It Skyrocketed by 33%? - Nasdaq
Analysts Set Doximity, Inc. (NASDAQ:DOCS) Target Price at $31.27 - MarketBeat
Reconsidering Doximity Shares: Should Investors Bet On Sustained Revenue Growth Inflection - Seeking Alpha
Lecap Asset Management Ltd. Invests $625,000 in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
First Horizon Advisors Inc. Buys 760 Shares of Doximity, Inc. (NASDAQ:DOCS) - Defense World
Doximity: The 'Facebook for Doctors' Surges After Earnings Beat - sharewise
Jefferies raises Doximity price target to $43 from $35, keeps buy rating - Investing.com Australia
Doximity: The 'Facebook for Doctors' Surges After Earnings Beat - MarketBeat
SG Americas Securities LLC Buys 3,659 Shares of Doximity, Inc. (NASDAQ:DOCS) - Defense World
Doximity (NASDAQ:DOCS) PT Raised to $40.00 at Canaccord Genuity Group - MarketBeat
Jefferies raises Doximity price target to $43 from $35, keeps buy rating - Investing.com India
Canaccord Genuity Group Increases Doximity (NASDAQ:DOCS) Price Target to $40.00 - Defense World
Canaccord Genuity backs Doximity stock as new Portal expands market reach - Investing.com Canada
Canaccord Genuity backs Doximity stock as new Portal expands market reach - Investing.com
Doximity (NASDAQ:DOCS) Price Target Raised to $30.00 at JPMorgan Chase & Co. - MarketBeat
Doximity (NASDAQ:DOCS) PT Raised to $30.00 at JPMorgan Chase & Co. - Defense World
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump - Simply Wall St
Swedbank AB Decreases Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
DOXIMITY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Doximity, Inc.DOCS - Business Wire
Doximity (NASDAQ:DOCS) Stock Rating Reaffirmed by Truist Financial - Defense World
Why Doximity Shares Are Trading Higher Today - MSN
Investigation announced for Long-Term Investors in shares of Doximity, Inc. (NYSE: DOCS) over potential Wrongdoing - openPR
Doximity (NASDAQ:DOCS) Stock Rating Reaffirmed by Truist Financial - MarketBeat
Doximity director Cabral sells over $1.19 million in company stock By Investing.com - Investing.com Australia
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - Longview News-Journal
A Closer Look at 8 Analyst Recommendations For Doximity - Benzinga
Doximity director Cabral sells over $1.19 million in company stock - Investing.com
Doximity director Cabral sells over $1.19 million in company stock By Investing.com - Investing.com UK
Truist Securities lifts Doximity stock target, maintains hold on FY25 revenue estimate - Investing.com
Piper Sandler raises Doximity stock target price on strong earnings By Investing.com - Investing.com Australia
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo Finance
Doximity (NASDAQ:DOCS) Trading Up 4% on Analyst Upgrade - Defense World
LTH vs. DOCS: Which Stock Should Value Investors Buy Now? - Yahoo Finance UK
Doximity: Q1 Revenue, Net Income Soar - The Motley Fool
Doximity (NASDAQ:DOCS) Stock Price Up 4% Following Analyst Upgrade - MarketBeat
Piper Sandler raises Doximity stock target price on strong earnings By Investing.com - Investing.com UK
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Doximity, Inc. (NYSE: DOCS) - EIN News
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):